Optometry

Top Story

New therapies target dry eye, conjunctivitis, redness, presbyopia

June 23, 2017

WASHINGTON – Paul M. Karpecki, OD, FAAO, reported on new and up-and-coming ocular therapeutics at a continuing education session here at Optometry’s Meeting.

Allergan received FDA approval in April to market TrueTear intranasal tear neurostimulator.

In the JournalsVideo

VIDEO: Physicians can benefit from big data

June 24, 2017
NEWPORT BEACH, Calif. ― At the OCTANe Ophthalmology Technology Summit, John A. Hovanesian, MD, discusses a panel he moderated here discussing the role of big data, how…
Meeting NewsVideo

VIDEO: SLT viable first-line glaucoma treatment

June 24, 2017
WASHINGTON – Nate Lighthizer, OD, gave a workshop on lasers here at Optometry’s Meeting, discussing and teaching ODs how to perform selective laser…
Meeting NewsVideo

VIDEO: Mazzo discusses cooperation of large, small companies in ophthalmology

June 23, 2017
NEWPORT BEACH, Calif. ― At the OCTANe Ophthalmology Technology Summit here, Jim Mazzo, global president of ophthalmic devices at Carl Zeiss Meditec, discusses how…
Meeting NewsVideo

VIDEO: OCTANe CEO discusses formula for growing business in Orange County

June 23, 2017
NEWPORT BEACH, Calif. ― At the OCTANe Ophthalmology Technology Summit here, Bill Carpou, CEO of OCTANe, discusses the goals of the meeting and how OCTANe is working to…
More News Headlines »
CME

Scratching Beneath the Surface to Manage Ocular Surface Disease

This activity is supported by an educational grant from Shire.

Dry eye disease (DED) is a condition of the ocular surface in which multiple factors are responsible for the…
More »
Video
Meeting News

VIDEO: Mazzo discusses cooperation of large, small companies in ophthalmology

June 23, 2017
More »
Featured
Optometry's Meeting

Optometry's Meeting

Video
Meeting News

VIDEO: Amniotic membrane speeds healing

June 23, 2017
More »
Current Issues
View the Current Issue
Primary Care Optometry News
Advertisement
Advertisement